Literature DB >> 12637125

Approaches to pharmacy benefit management and the impact of consumer cost sharing.

Bridget M Olson1.   

Abstract

BACKGROUND: Numerous mechanisms have been introduced to deliver prescription drug benefits while controlling pharmaceutical costs. An understanding of the most prominent mechanisms of benefit management is an important step in determining the most effective approach to take in future years.
OBJECTIVES: The aims of this review were to illustrate the mechanisms by which managed care has attempted to efficiently and equitably deliver pharmacy benefits and to discuss the impact of such programs, including consumer cost sharing.
METHODS: A review of the literature was conducted using the PreMedline and MEDLINE databases from the years 1966 to 2002, reference lists from relevant articles, and online sources, including news releases, conference materials, and pharmacy benefit management reports.
RESULTS: Numerous pharmacy benefit management tools and their impact on utilization, expenditures, and health outcomes are reviewed, including disease state management; utilization management (ie, quantity limitations and prior authorization); drug utilization review; formulary management (ie, open and closed); delivery systems (ie, retail and mail order); and mechanisms for implementing consumer cost sharing (ie, generic incentives, multitiered copayments, and co-insurance). Although there is some evidence to suggest that certain benefit management tools have been successful in reducing health plan expenditures, a more thorough investigation of their potential unintended consequences is needed.
CONCLUSIONS: Implementing adequate levels of consumer cost sharing is necessary if employers and health plans are to continue offering prescription drug benefits. It is important to remember, however, that quality health care cannot be forfeited for the sake of short-term cost savings.

Mesh:

Year:  2003        PMID: 12637125     DOI: 10.1016/s0149-2918(03)90035-x

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  9 in total

Review 1.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Availability of addiction medications in private health plans.

Authors:  Constance M Horgan; Sharon Reif; Dominic Hodgkin; Deborah W Garnick; Elizabeth L Merrick
Journal:  J Subst Abuse Treat       Date:  2007-05-17

Review 3.  The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries.

Authors:  Andrew Lofts Gray; Fatima Suleman
Journal:  Int J Clin Pharm       Date:  2015-07-17

4.  Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.

Authors:  James L Raper; James H Willig; Hui-Yi Lin; Jeroan J Allison; M Bennet Broner; Michael J Mugavero; Michael S Saag
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

5.  Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project.

Authors:  L Kay Bartholomew; William C Cushman; Jeffrey A Cutler; Barry R Davis; Glenna Dawson; Paula T Einhorn; James F Graumlich; Linda B Piller; Sara Pressel; Edward J Roccella; Lara Simpson; Paul K Whelton; Angela Williard
Journal:  Clin Trials       Date:  2009-07-08       Impact factor: 2.486

6.  Prior authorization of newer insomnia medications in managed care: is it cost saving?

Authors:  Rajesh Balkrishnan; Vijay N Joish; Monali J Bhosle; Rafia S Rasu; Milap C Nahata
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

7.  Access to Addiction Pharmacotherapy in Private Health Plans.

Authors:  Sharon Reif; Constance M Horgan; Dominic Hodgkin; Ann-Marie Matteucci; Timothy B Creedon; Maureen T Stewart
Journal:  J Subst Abuse Treat       Date:  2016-03-14

8.  Improving Insurance and Health Care Systems to Ensure Better Access to Sexually Transmitted Disease Testing and Prevention.

Authors:  Alice J Lee; Madeline C Montgomery; Rupa R Patel; Julia Raifman; Lorraine T Dean; Philip A Chan
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 3.868

9.  Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization.

Authors:  Samuel K Peasah; Monal Kohli; Kiraat D Munshi; Rochelle Henderson; Mark Mueller; Chronis Manolis; Yan Huang; Elizabeth C S Swart; Lynn Neilson; Chester B Good
Journal:  Explor Res Clin Soc Pharm       Date:  2021-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.